Levi Garraway, Chief Medical Officer, Executive Vice President, Head of Global Product Development and DirectorLinkedin
Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Market Report (2022 to 2030) - Pfizer Inc., Novartis AG, Genentech, Inc., GlaxoSmithKline Plc. and LFB BiomedicamentsFeb 8, 2023
Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in OncologyJan 9, 2023
Biogen Reaches Agreement with Genentech to Receive Royalties on the Potential Commercialization of a Late-Stage Bispecific Antibody as Part of Anti-CD20 CollaborationDec 19, 2022
COUR Pharmaceuticals, Boehringer Ingelheim, Genentech, GSK, Idorsia Pharmaceuticals: Veeva Commercial SummitNov 15, 2022